• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[1990年抗菌剂对从尿路感染分离出的病原体的活性比较研究。I. 敏感性分布]

[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1990). I. Susceptibility distribution].

作者信息

Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H

机构信息

Department of Urology, School of Medicine, Sapporo Medical College.

出版信息

Jpn J Antibiot. 1995 Oct;48(10):1295-316.

PMID:8544334
Abstract

The frequencies of isolation and susceptibilities to antimicrobial agents were investigated on 848 bacterial strains isolated from patients with urinary tract infections in 10 hospitals during the period of June 1990 to May 1991. Of the above total bacterial isolates, Gram-positive bacteria accounted for 23.9% and a majority of them were Enterococcus faecalis. Gram-negative bacteria accounted for 76.1% and most of them were Escherichia coli. 1. Enterococcus faecalis: Ampicillin (ABPC), imipenem (IPM) and vancomycin (VCM) showed the highest activities against E. faecalis isolated from patients with urinary tract infections. The MIC90s of them were 2 micrograms/ml. Piperacillin (PIPC) was also active with the MIC90 of 4 micrograms/ml. The others were not so active with the MIC90s of 32 micrograms/ml or above. 2. Staphylococcus aureus: VCM and arbekacin (ABK) showed the highest activities against S. aureus isolated from patients with urinary tract infections. The MIC90s of them were 1 micrograms/ml. The others were not so active with the MIC90s of 32 micrograms/ml or above. 3. Escherichia coli: Cefozopran (CZOP), carumonam (CRMN) and ofloxacin (OFLX) showed the highest activities against E. coli isolated from patients with urinary tract infections. The MIC90s of them were of 0.125 microgram/ml or below. IPM, cefotiam (CTM) and cefmenoxime (CMX) were also active with the MIC90s of 0.25 micrograms/ml. Penicillins were not so active with the MIC90s of 32 micrograms/ml or above. 4. Klebsiella pneumoniae: Flomoxef (FMOX), cefixime (CFIX), CZOP and CRMN showed the highest activities against K. pneumoniae isolated from patients with urinary tract infections. The MIC90s of them were of 0.125 microgram/ml or below. IPM and gentamicin (GM) were also active with the MIC90s of 0.25 microgram/ml and 0.5 microgram/ml, respectively. All other cephems were also active with the MIC90s of 4 micrograms/ml or below. 5. Citrobacter freundii: GM and IPM showed the highest activities against C. freundii isolated from patients with urinary tract infections. The MIC90s of them were 1 microgram/ml. Amikacin (AMK) was also active with the MIC90 of 4 micrograms/ml. The others were not so active. 6. Enterobacter cloacae: IPM and GM showed the highest activities against E. cloacae isolated from patients with urinary tract infections. The MIC90s of them MIC90s of 0.5 microgram/ml. AMK and OFLX were also active with the MIC90s of 4 micrograms/ml. Penicillins and cephems generally showed lower activities. 7. Proteus mirabilis: Most of the agents were active against P. mirabilis. Cephems were generally active with the MIC90s in a range of < or = 0.125 microgram/ml-4 micrograms/ml.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

对1990年6月至1991年5月期间从10家医院的尿路感染患者中分离出的848株细菌菌株,研究了其分离频率及对抗菌药物的敏感性。在上述全部细菌分离株中,革兰氏阳性菌占23.9%,其中大多数为粪肠球菌。革兰氏阴性菌占76.1%,其中大多数为大肠杆菌。1. 粪肠球菌:氨苄西林(ABPC)、亚胺培南(IPM)和万古霉素(VCM)对从尿路感染患者中分离出的粪肠球菌显示出最高活性。它们的MIC90为2微克/毫升。哌拉西林(PIPC)也有活性,MIC90为4微克/毫升。其他药物活性较低,MIC90为32微克/毫升或更高。2. 金黄色葡萄球菌:VCM和阿贝卡星(ABK)对从尿路感染患者中分离出的金黄色葡萄球菌显示出最高活性。它们的MIC90为1微克/毫升。其他药物活性较低,MIC90为32微克/毫升或更高。3. 大肠杆菌:头孢唑兰(CZOP)、卡芦莫南(CRMN)和氧氟沙星(OFLX)对从尿路感染患者中分离出的大肠杆菌显示出最高活性。它们的MIC90为0.125微克/毫升或更低。IPM、头孢替安(CTM)和头孢甲肟(CMX)也有活性,MIC90为0.25微克/毫升。青霉素类药物活性较低,MIC90为32微克/毫升或更高。4. 肺炎克雷伯菌:氟氧头孢(FMOX)、头孢克肟(CFIX)、CZOP和CRMN对从尿路感染患者中分离出的肺炎克雷伯菌显示出最高活性。它们的MIC90为0.125微克/毫升或更低。IPM和庆大霉素(GM)也有活性,MIC90分别为0.25微克/毫升和0.5微克/毫升。所有其他头孢菌素类药物也有活性,MIC90为4微克/毫升或更低。5. 弗劳地枸橼酸杆菌:GM和IPM对从尿路感染患者中分离出的弗劳地枸橼酸杆菌显示出最高活性。它们的MIC90为1微克/毫升。阿米卡星(AMK)也有活性,MIC90为4微克/毫升。其他药物活性较低。6. 阴沟肠杆菌:IPM和GM对从尿路感染患者中分离出的阴沟肠杆菌显示出最高活性。它们的MIC90为0.5微克/毫升。AMK和OFLX也有活性,MIC90为4微克/毫升。青霉素类和头孢菌素类药物一般活性较低。7. 奇异变形杆菌:大多数药物对奇异变形杆菌有活性。头孢菌素类药物一般有活性,MIC90范围为≤0.125微克/毫升至4微克/毫升。(摘要截短至400字)

相似文献

1
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1990). I. Susceptibility distribution].[1990年抗菌剂对从尿路感染分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1995 Oct;48(10):1295-316.
2
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].[1992年抗微生物剂对从尿路感染分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1995 Nov;48(11):1627-57.
3
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].[1993年抗菌药物对从尿路感染分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1995 Nov;48(11):1757-87.
4
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution].[1994年抗微生物药物对从尿路感染患者分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1996 May;49(5):465-93.
5
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1995). I. Susceptibility distribution].[1995年抗微生物药物对从尿路感染患者分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1997 Mar;50(3):219-50.
6
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].[1996年抗微生物药物对尿路感染患者分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1998 Feb;51(2):69-111.
7
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].[1997年抗微生物药物对从尿路感染患者分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1999 Feb;52(2):93-129.
8
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].[1989年抗微生物剂对从尿路感染分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1995 Sep;48(9):1131-60.
9
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1991). I. Susceptibility distribution].[1991年抗微生物药物对从尿路感染分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1995 Oct;48(10):1394-421.
10
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1986). I. Susceptibility distribution].[1986年抗微生物剂对从尿路感染分离出的病原体的活性比较研究。I. 敏感性分布]
Jpn J Antibiot. 1989 Oct;42(10):2141-73.